{"id":"W2164218337","doi":"10.1111/j.1365-4632.2006.02777.x","title":"Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial","year":2006,"lang":"en","type":"article","venue":"International Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Western University","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Placebo; Adverse effect; Psoriasis Area and Severity Index; Tolerability; Internal medicine; Randomized controlled trial; Incidence (geometry); Dermatology; Gastroenterology; Plaque psoriasis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002614869,0.0002268808,0.001619018,0.0005317605,0.00003748933,0.00001167042,0.0003455573,0.0002155952,0.0001795078],"category_scores_gemma":[0.00013728,0.0001545673,0.0003693438,0.0001093364,0.0001295008,0.0001295744,0.00003475189,0.0002013511,0.0000215751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001465644,"about_ca_system_score_gemma":0.0003854861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001249334,"about_ca_topic_score_gemma":0.0003581781,"domain_scores_codex":[0.9973145,0.0006518956,0.001470199,0.0001835528,0.0001309358,0.0002489296],"domain_scores_gemma":[0.9978315,0.0006605737,0.0009401974,0.0001194455,0.0004186887,0.0000296221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9898498,0.0008554344,0.0002504742,0.00001041648,0.001994392,0.0007604425,0.0002968163,0.0005102071,0.001151855,0.002118035,0.0003113699,0.001890732],"study_design_scores_gemma":[0.9818602,0.000686128,0.00006988354,0.0002246309,0.0002669583,0.007711885,0.00005307841,0.00006470645,0.007795938,0.0003774017,0.0007424328,0.0001467309],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900621,0.002415553,0.001292793,0.002070501,0.002015933,0.001223176,0.0000484287,0.00001105078,0.0008604301],"genre_scores_gemma":[0.9989613,0.000231445,0.0002011987,0.00005151078,0.0001864545,0.0001012208,0.00005449773,0.00001384968,0.0001985686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00889912,"threshold_uncertainty_score":0.6303073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005841247212327164,"score_gpt":0.2477596451481913,"score_spread":0.2419183979358641,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}